TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 28 filers reported holding TALIS BIOMEDICAL CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $109,728 | +9.9% | 223,934 | 0.0% | 0.01% | +40.0% |
Q4 2022 | $99,807 | -34.8% | 223,934 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $153,000 | -15.9% | 223,934 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $182,000 | -49.7% | 223,934 | -12.7% | 0.01% | -50.0% |
Q1 2022 | $362,000 | -52.1% | 256,395 | +36.2% | 0.01% | -47.4% |
Q4 2021 | $755,000 | +880.5% | 188,269 | +1426.1% | 0.02% | +850.0% |
Q3 2021 | $77,000 | – | 12,337 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greenlight Capital | 2,235,783 | $1,095,534 | 0.06% |
Baker Brothers Advisors | 7,624,835 | $3,736,169 | 0.02% |
PRELUDE CAPITAL MANAGEMENT, LLC | 223,934 | $109,728 | 0.01% |
ArrowMark Colorado Holdings LLC | 478,862 | $234,642 | 0.00% |
WELLS FARGO & COMPANY/MN | 167 | $82 | 0.00% |
NORTHERN TRUST CORP | 27,860 | $13,652 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 144,416 | $70,763 | 0.00% |
STATE STREET CORP | 49,536 | $24,273 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 163,663 | $80 | 0.00% |